FHI — Federated Hermes, Inc. Class B

Deep-value: FHI — Federated Hermes, Inc. (Class B, NYSE)

Analysis date: 2026-08-25 · Reference price: USD … (close 2026-08-24) · Shares outstanding: 74.909 mil. (2026-06-30) · Market cap: USD 4.85 bn · Reporting currency: USD (identical to the price currency — no conversion needed)

Primary sources: 10-K FY2025 (filed 2026-02-27), 10-K FY2024/FY2023/FY2022/FY2021, 10-Q Q1 2026 (2026-05-01), 10-Q Q2 2026 (2026-07-31), 10-Q Q1–Q3 2025, DEF 14C from 2026-03-17, Q2 2026 earnings call transcript (2026-07-31), data pack data-pack-FHI-20260824.md, simulation mc-FHI-20260825.json.

Executive summary (1 page: thesis, estimated value, verdict)

The thesis in three sentences. Federated Hermes is an asset manager founded in 1955, fully controlled by the Donahue family through 9,000 Class A shares held in a voting trust, which manages USD 911.6 bn (2026-06-30) of which USD 676.9 bn — 74% — are money market funds. The business has the economics of a liquidity tax: near-zero fixed capital (capex USD 2.8 mil. in 2025 versus depreciation of 22.3 mil.), 2,091 employees managing USD 432 mil. of assets per head, ROE of 35%, and net profit that practically equals free cash flow to the shareholder. The price, however, no longer reflects even half the pessimism it embedded two years ago: the stock rose from USD 33.86 (2023-12-31) to …, i.e. … in 32 months, while EPS grew from 3.40 to 5.38 (…) — the rest is multiple re-rating.

The flow choice (detailed in the valuation chapter). FHI’s reported CFO is systematically distorted by the Consolidated Investment Companies: the net securities purchases made by these funds appear as an operating outflow (USD 146.1 mil. in 2025, 94.4 mil. ttm), even though the money is mostly third parties’ and comes in through financing (minority contributions of 163.9 mil. in 2025). Whoever takes “CFO − capex” at face value gets USD 294.6 mil. for 2025 and wrongly concludes that the 403.3 mil. profit is low-quality. After stripping out the consolidated-fund transactions, subtracting minority interests, and treating stock compensation as a real cost (not added back), FCFE 2025 = USD 403.1 mil., i.e. 99.95% of the 403.3 mil. attributable net profit. Over the trailing 12 months (through 2026-06-30), FCFE = USD 435.2 mil., a 9.0% yield at the current price. The normalized base used in the DCF: USD 410 mil.

Estimated value. Five triangulated models produce a brutally wide range, and the width is the main message:

Monte Carlo (20,000 scenarios, same central assumptions as model 2): median intrinsic value …, median MOS …, probability of undervaluation …, but a P5–P95 range from … to ….

Verdict: WATCH, don’t buy at …. The business deserves to be owned; today’s price offers no margin of safety. The three anchors that don’t depend on a ten-year growth forecast — EPV (…), historical multiples (…), and analyst consensus (average target USD 61.14, “hold,” 7 analysts) — all say the same thing: the stock is fairly valued to slightly expensive. The only model that gives serious upside is the DCF, and it has … of its value in the terminal term and assumes 4% annual growth for ten years at a company whose money-market share has been flat for the last 7.5 years (gained share in 14 quarters, lost it in 14) and whose long-term assets had net outflows in both prior years. Accumulation threshold: below USD 55, where EPV turns positive and the zero-rate scenario stops being a permanent capital loss. Position size, if taken: small — the 143-percentage-point P5–P95 range doesn’t support a high-conviction position.